300 patients monitored to uncover early signs of blood cancer

NCT ID NCT04428489

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: The First Affiliated Hospital of Soochow University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 300 people with persistent low blood cell counts (cytopenia) who do not yet have myelodysplastic syndromes (MDS), a type of blood cancer. Researchers aim to track how often these pre-MDS conditions (called ICUS and CCUS) progress to MDS. Participants receive only supportive care, and no experimental treatment is given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could clarify which patients with early blood abnormalities are at risk of developing myelodysplastic syndromes, guiding future monitoring and treatment strategies.
What could go wrong: This is an observational study, not a treatment trial. It only tracks disease progression without testing any intervention, so it cannot directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myelodysplastic syndrome Myelodysplastic Syndromes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYELODYSPLASTIC SYNDROMES

Contacts and locations

Locations

The First Affliated Hospital of Soochow University

Suzhou, Jiangsu, 215006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.